gip/glp-1 receptor agonist GIP Agonism Attenuates GLP-1 Receptor Induced Nausea and Emesis in Preclinical Models — Hayes Lab GLP-1 Receptor Agonists Explained for
Description
Bioorg Med Chem
This effect is exactly what makes these medications potentially dangerous for people with eating disorders
However, clinical trials have shown semaglutide to be effective in aiding weight loss in patients with obesity
This hormone activates GLP-1 receptors in the enteric nervous system and through vagal pathways that influence digestive function
Many users find that having food available constantly but eating small amounts works better than scheduled larger meals
